Cell-penetrating peptides: a comparative membrane toxicity study. - Wikidata - wikimedia - TriplyDB

Cell-penetrating peptides: a comparative membrane toxicity study.

Cell-penetrating peptides: a comparative membrane toxicity study.

http://www.wikidata.org/entity/Q46682692

about

The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease Organelle targeting: third level of drug targeting Dihydroimidazophenanthridinium (DIP)-based DNA binding agents with tuneable structures and biological activity.Binding of Sudan II and IV to lecithin liposomes and E. coli membranes: insights into the toxicity of hydrophobic azo dyes.LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.Distribution of CPP-Protein Complexes in Freshly Resected Human Tissue Material.Structure analysis and conformational transitions of the cell penetrating peptide transportan 10 in the membrane-bound state.Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.siRNA delivery to CNS cells using a membrane translocation peptide Design of embedded chimeric peptide nucleic acids that efficiently enter and accurately reactivate gene expression in vivo Lipid-mediated DNA and siRNA Transfection Efficiency Depends on Peptide Headgroup A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling Electrochemical impedimetric biosensor based on a nanostructured polycarbonate substrate.Transportan 10 improves the anticancer activity of cisplatin.Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery.Comparative study on transduction and toxicity of protein transduction domains.An Intrinsically Disordered Peptide Facilitates Non-Endosomal Cell Entry.Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.A common landscape for membrane-active peptides.Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection Cell-penetrating peptides for drug delivery across membrane barriers.Lipid vesicles as membrane models for toxicological assessment of xenobiotics.Targeted delivery of ubiquitin-conjugated BH3 peptide-based Mcl-1 inhibitors into cancer cells Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.Improving the transport of chemotherapeutic drugs across the blood-brain barrier.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Peptide-mediated delivery: an overview of pathways for efficient internalization.Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity.Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel.Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells.Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery.Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells.Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy.Bioportide: an emergent concept of bioactive cell-penetrating peptides.Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer.Translocation of cell-penetrating peptides into Candida fungal pathogens.3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases.

P2860

Q26745586-C4BF3F68-1E91-4E2D-827E-F2BB3461CDFD Q26767093-F8DF5EB0-4A56-4606-AB85-4BFDB9810A93 Q27014902-A6CD7D27-CA89-49A5-B940-1E129E9AF406 Q33259956-8F7652E3-D85B-4F96-B22E-7A27AE03AA69 Q33280170-3FCD6D75-B57A-4547-9F00-624A24BCEFFF Q33580471-4939A8B9-9A2A-46ED-9B77-2AFDE4C6F60D Q33664219-D523F55C-0DE7-4067-A1D1-76CDBD1090F4 Q33769108-0B2BA2F9-73B7-4327-AEA7-CF6D97123506 Q33824686-FB6EFED8-89AF-46E9-B10D-A70B466339EE Q33868053-A33628F6-216F-4E68-99D1-6C4AF906E7FE Q34165634-9A196AC1-E9D8-4956-851F-9C2ABF31F825 Q35082289-3C2CCC95-0961-4C76-AE98-0D04335471EE Q35285871-AC7F6E5B-25C4-4D7F-A20A-C3CAF95A6436 Q35679874-BA9F0441-FF1B-4390-8CE8-62E2377D549C Q35930103-DE5A9A4D-6E80-4383-8629-7340456DE025 Q35953315-A594A6B6-6E1A-473F-89C3-32DBCD6F0D0B Q36510057-3930C0D9-9B5B-4C4A-8CAB-99E0720E03DD Q36763669-48AED0EA-C737-4C19-A373-BB39E5C22F7C Q36765566-0AB9ACEF-3162-4399-9B3B-89BA60BB6367 Q37034573-81D8C23C-DBF6-4A19-8A93-2A958618708F Q37036638-876C52FF-CFB2-43D8-9075-AB06A9DBD122 Q37039034-B93D2DA2-141E-4699-96A1-CA4459F2D72B Q37045660-A5DBD942-C456-44FD-B231-CE8EDAE3A460 Q37682695-1193BEB6-5FAD-4AD8-B1B3-600F802B681A Q37923355-98BA4E50-0467-4414-9CC9-B680514FDA52 Q37960529-B09331AE-CDDF-4993-BE3E-4D5DF8FDEDF8 Q38238902-4D188EA9-8E0B-4F3B-8B64-993BF633A48D Q38285852-6D83F6E8-2583-40C3-A488-49C97AECD65D Q38644876-A6370273-7A38-4585-AE9C-E42BE555114D Q38765936-8C6A6068-EE5D-43EE-AE28-92990C8F9568 Q38913162-05AE407C-E4D6-4DD9-85A9-074D77B1B5C2 Q39252765-C1B5D4B5-6E8A-469F-91C8-544BA5CAF99C Q40060358-C0B6A6AE-0CD5-4FC1-8B08-9C5DBC4B55EA Q40254465-5C465F8A-49B4-4E84-8C1F-0D829D8376EA Q41888109-FC04232B-222E-43F3-9AE8-213F0412905A Q42283138-5D50CD83-4E09-44F8-BC1B-37D56CBA8D91 Q42979619-08ED87C8-18E5-496F-8626-A38D73D8EFB0 Q46269586-A18152C7-5797-4E1F-9AC0-A76EB50EDDEA Q46359263-31AC52AD-8CEA-445F-A8B0-1A54025C7BD2 Q46650139-B6698ADC-9BFB-4C5A-80F2-9D52B14D4B10

P2860

Cell-penetrating peptides: a comparative membrane toxicity study.

http://www.wikidata.org/entity/Q46682692

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Cell-penetrating peptides: a comparative membrane toxicity study.

@en

Cell-penetrating peptides: a comparative membrane toxicity study.

@nl

type

label

Cell-penetrating peptides: a comparative membrane toxicity study.

@en

Cell-penetrating peptides: a comparative membrane toxicity study.

@nl

prefLabel

Cell-penetrating peptides: a comparative membrane toxicity study.

@en

Cell-penetrating peptides: a comparative membrane toxicity study.

@nl

P1433

Q46682692-E4A1D49F-1094-4929-9199-48F102A3093B

P1476

Q46682692-17EDCCC8-5A9E-44C9-B00B-0EBFC936DBE9

P2093

Q46682692-0A6E70FD-9632-4AB4-AFFF-011755587784

Q46682692-2F9612C3-325A-4567-AD3D-8F7B83672FC5

Q46682692-521F3B65-08B6-4429-9C57-ABA3CA146B5A

Q46682692-7196FE15-FEF8-4885-9770-831C120BBAB5

Q46682692-7C0B226C-0ED1-425F-88CA-2C19E6B38005

Q46682692-870549A7-0068-4D0E-9742-AB35FC3E83E6

Q46682692-D510CED8-A3A6-47C4-A9E3-9BE7443C4EB0

Q46682692-FEEE8BD3-E8E5-406F-9253-37EF6C829594

P304

Q46682692-F3CEA64F-7F9F-4CAF-9EB5-EFDE8474A168

P31

Q46682692-5EDA405B-F7EA-4233-AF57-311197CC1317

P356

Q46682692-F1C1280E-9F7E-407E-A54C-1640437FCDBB

P407

Q46682692-0135C9D5-30F9-4D07-ABA0-D8F6F7A5EE4A

P433

Q46682692-E5B2A1EF-C283-4416-BD6A-1293FC8D6798

P478

Q46682692-ECCB8C89-32BF-4CF3-B271-8ED670695E7E

P50

Q46682692-0E566FAE-332A-48FA-9FBE-0AA9218BA536

Q46682692-858611D6-C31E-4DDA-821B-BBDD4B198B5E

Q46682692-9CCEB4ED-88E4-4DC1-8703-13A037830F77

Q46682692-E5430A2C-8458-4AA4-8DFF-C43F6CA275B3

P577

Q46682692-38933A05-FC18-4EDE-8F05-A9AE5A2BC897

P5875

Q46682692-5E0E0885-AFF4-4431-BD49-DF7ECB7DB217

P698

Q46682692-C9ADD253-4F44-4417-A256-B9FB6E85AC6D

P356

J.AB.2005.07.033

P1433

Analytical Biochemistry

P1476

Cell-penetrating peptides: a comparative membrane toxicity study.

@en

P2093

Emelía Eiríksdóttir

http://www.w3.org/2001/XMLSchema#string

Katri Rosenthal-Aizman

http://www.w3.org/2001/XMLSchema#string

Külliki Saar

http://www.w3.org/2001/XMLSchema#string

Maria Lindgren

http://www.w3.org/2001/XMLSchema#string

Mats Hansen

http://www.w3.org/2001/XMLSchema#string

Meeri Sassian

http://www.w3.org/2001/XMLSchema#string

Ulo Langel

http://www.w3.org/2001/XMLSchema#string

Yang Jiang

http://www.w3.org/2001/XMLSchema#string

P304

55-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AB.2005.07.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P50

Emelía Eiríksdóttir

Katri Rosenthal-Aizman

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7622932

http://www.w3.org/2001/XMLSchema#string

P698

16137634

http://www.w3.org/2001/XMLSchema#string